What do human pregnancy data show about the risk of birth defects with abacavir?

Human pregnancy data from more than 800 first-trimester and more than 1,000 second- and third-trimester exposure outcomes indicate no malformative or foetal/neonatal effects of abacavir, making birth-defect risk unlikely based on these data.